Propel Bio Management 13F annual report

Propel Bio Management is an investment fund managing more than $172 billion ran by Jim Harding. There are currently 28 companies in Mr. Harding’s portfolio. The largest investments include Applied Therapeutics and Plains Gp Holdings Lp-cl, together worth $69.5 billion.

$172 billion Assets Under Management (AUM)

As of 5th August 2024, Propel Bio Management’s top holding is 6,111,906 shares of Applied Therapeutics currently worth over $41.6 billion and making up 24.2% of the portfolio value. Relative to the number of outstanding shares of Applied Therapeutics, Propel Bio Management owns more than 0.1% of the company. In addition, the fund holds 1,492,581 shares of Plains Gp Holdings Lp-cl worth $28 billion. The third-largest holding is Tscan Therapeutics Inc worth $16.6 billion and the next is Madrigal Pharmaceuticals Inc worth $11.5 billion, with 43,032 shares owned.

Currently, Propel Bio Management's portfolio is worth at least $172 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Propel Bio Management

The Propel Bio Management office and employees reside in Los Angeles, California. According to the last 13-F report filed with the SEC, Jim Harding serves as the Finance Director at Propel Bio Management.

Recent trades

In the most recent 13F filing, Propel Bio Management revealed that it had opened a new position in Applied Therapeutics and bought 6,111,906 shares worth $41.6 billion.

One of the smallest hedge funds

The two most similar investment funds to Propel Bio Management are Marvin & Palmer Associates Inc and Alibaba Ltd. They manage $154 billion and $154 billion respectively.


Jim Harding investment strategy

Propel Bio Management’s portfolio is diversified across 3 sectors. Currently, their heaviest sector is Health Care — making up 67.3% of the total portfolio value. The fund focuses on investments in the United States as 60.7% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are small-cap stocks. Stocks with a size of more than $100 million in market cap make up 21% of the total holdings value. On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $539 million.

The complete list of Propel Bio Management trades based on 13F SEC filings

These positions were updated on August 12th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Applied Therapeutics, Inc.
Opened
6,111,906
$41,560,961,000 24.19%
Plains Gp Holdings Lp-cl
Opened
1,492,581
$27,978,962,000 16.29%
Tscan Therapeutics Inc
Opened
2,087,139
$16,571,884,000 9.65%
Madrigal Pharmaceuticals Inc
Opened
43,032
$11,491,265,000 6.69%
Achieve Life Sciences Inc.
Opened
2,453,092
$11,149,303,000 6.49%
Phathom Pharmaceuticals Inc
Opened
869,927
$9,238,625,000 5.38%
Akero Therapeutics Inc
Opened
327,752
$8,279,016,000 4.82%
Fulcrum Therapeutics Inc
Opened
750,000
$7,080,000,000 4.12%
Avidity Biosciences, Inc.
Opened
178,500
$4,555,320,000 2.65%
Day One Biopharmaceuticals I
Opened
270,664
$4,471,369,000 2.60%
Ardelyx Inc
Opened
594,174
$4,337,470,000 2.52%
Athira Pharma, Inc.
Opened
1,492,792
$4,090,250,000 2.38%
Kura Oncology Inc
Opened
130,000
$2,772,900,000 1.61%
Telesat Corp
Opened
290,781
$2,500,717,000 1.46%
Kymera Therapeutics, Inc.
Opened
56,359
$2,265,632,000 1.32%
iShares MBS ETF
Opened
22,400
$2,070,208,000 1.20%
Syndax Pharmaceuticals Inc
Opened
83,259
$1,981,564,000 1.15%
Mirum Pharmaceuticals Inc
Opened
70,000
$1,758,400,000 1.02%
Marinus Pharmaceuticals Inc
Opened
180,100
$1,628,104,000 0.95%
Kayne Anderson Energy Inf
Opened
147,033
$1,471,800,000 0.86%
Sutro Biopharma Inc
Opened
195,000
$1,101,750,000 0.64%
Trevi Therapeutics, Inc.
Opened
260,000
$897,000,000 0.52%
X4 Pharmaceuticals, Inc.
Opened
535,000
$743,650,000 0.43%
Eiger BioPharmaceuticals Inc
Opened
146,381
$731,905,000 0.43%
Ishares Iboxx Investment
Opened
4,456
$485,348,000 0.28%
Cybin Inc
Opened
850,000
$351,475,000 0.20%
Fidelity Inv Mmtrsy 1 680
Opened
211,541
$211,541,000 0.12%
Chinook Therapeutics Inc Cvr
Opened
79,357
$30,949,000 0.02%
No transactions found
Showing first 500 out of 28 holdings